Implementation of a critical pathway for complicated gallstone disease: translation of population-based data into

Kristin M Sheffield1, Kenia E Ramos, Clarisse D Djukom

  • 1Department of Surgery, The University of Texas Medical Branch, Galveston, TX, USA. kmsheffi@utmb.edu

Insights

Implementing a critical pathway significantly increased cholecystectomy rates during initial hospitalizations for gallstone disease. This approach also reduced hospital stays and readmissions, improving patient outcomes and lowering healthcare costs.

Area of Science:

  • Surgical outcomes research
  • Healthcare quality improvement
  • Gastrointestinal surgery

Background:

  • Evidence-based guidelines advocate for cholecystectomy during initial hospitalization for complicated gallstone disease.
  • Previous studies indicated suboptimal cholecystectomy rates, ranging from 40% to 75%, during index admissions.

Purpose of the Study:

  • To evaluate the impact of a critical pathway on cholecystectomy rates for patients with acute cholecystitis, mild gallstone pancreatitis, or common bile duct stones.
  • To assess changes in time to surgery, length of hospital stay, and readmission rates post-pathway implementation.

Main Methods:

  • A multidisciplinary critical pathway was implemented in January 2009 for emergent admissions related to gallstone disease.
  • Cholecystectomy rates, time to surgery, length of stay, and readmission rates were compared between pre-pathway (Jan 2005-Feb 2008) and post-pathway (Jan 2009-May 2010) cohorts.

Main Results:

  • Cholecystectomy rates during initial hospitalization rose from 48% to 78% (p < 0.0001) post-pathway implementation.
  • Mean length of stay decreased from 7.1 to 4.5 days (p < 0.0001), with a reduced time from admission to cholecystectomy (4.1 to 2.1 days; p < 0.0001).
  • Readmission rates for gallstone-related issues or complications dropped significantly from 33% to 10% (p < 0.0001), reducing associated costs.

Conclusions:

  • A multidisciplinary critical pathway effectively improved initial hospitalization cholecystectomy rates for complicated gallstone disease.
  • Pathway implementation led to shorter hospital stays and significantly decreased readmission rates, thereby reducing overall healthcare costs.
  • Wider adoption of such pathways can translate evidence-based guidelines into practice and minimize medical care expenses.
Abstract

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Endoscopic Procedures V: ERCP01:26

Endoscopic Procedures V: ERCP

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...